1887

Abstract

The CmeABC efflux pump plays an important role in the antimicrobial resistance of and . The aim of this investigation was to study the effect of putative efflux pump inhibitors, phenyl-arginine--naphthylamide (PAN) and 1-(1-naphthylmethyl)-piperazine (NMP), as well as the effect of putative efflux pump inducers, sodium salicylate and sodium deoxycholate, on the MIC levels of erythromycin, ciprofloxacin, kanamycin, tetracycline and rifampicin for and . Our results indicated that susceptibility to erythromycin and rifampicin increased, respectively, 8- to 32- and 8- to 64-fold in the presence of PAN and to a lesser extent in the presence of NMP. Salicylate produced a 2- to 4-fold increase in ciprofloxacin MIC values, whereas little effect was observed in the presence of deoxycholate.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47823-0
2008-07-01
2019-10-18
Loading full text...

Full text loading...

/deliver/fulltext/jmm/57/7/851.html?itemId=/content/journal/jmm/10.1099/jmm.0.47823-0&mimeType=html&fmt=ahah

References

  1. Aumercier, M., Murray, D. M. & Rosner, J. L. ( 1990; ). Potentiation of susceptibility to aminoglycosides by salicylate in Escherichia coli. Antimicrob Agents Chemother 34, 786–791.[CrossRef]
    [Google Scholar]
  2. Bohnert, J. A. & Kern, W. V. ( 2005; ). Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob Agents Chemother 49, 849–852.[CrossRef]
    [Google Scholar]
  3. Bolla, J. M., Loret, E., Zalewski, M. & Pagés, J. M. ( 1995; ). Conformational analysis of the Campylobacter jejuni porin. J Bacteriol 177, 4266–4271.
    [Google Scholar]
  4. Cagliero, C., Mouline, C., Payot, S. & Cloeckaert, A. ( 2005; ). Involvement of the CmeABC efflux pump in the macrolide resistance of Campylobacter coli. J Antimicrob Chemother 56, 948–950.[CrossRef]
    [Google Scholar]
  5. CLSI ( 2006; ). Performance Standards for Antimicrobial Susceptibility Testing. Supplement M100–S16. Wayne, PA: Clinical and Laboratory Standards Institute.
  6. Corcoran, D., Quinn, T., Cotter, L., O'Halloran, F. & Fanning, S. ( 2005; ). Characterization of a cmeABC operon in a quinolone-resistant Campylobacter coli isolate of Irish origin. Microb Drug Resist 11, 303–308.[CrossRef]
    [Google Scholar]
  7. Friedman, C. R., Neimann, J., Wegener, H. C. & Tauxe, R. V. ( 2000; ). Epidemiology of Campylobacter jejuni infections in the United States and other industrialized nations. In Campylobacter, 2nd edn, pp. 121–138. Edited by I. Nachamkin & M. J. Blaser. Washington, DC: American Society for Microbiology.
  8. Gibreel, A., Wetsch, N. M. & Taylor, D. E. ( 2007; ). Contribution of the CmeABC efflux pump to macrolide and tetracycline resistance in Campylobacter jejuni. Antimicrob Agents Chemother 51, 3212–3216.[CrossRef]
    [Google Scholar]
  9. Hänninen, M. L. & Hannula, M. ( 2007; ). Spontaneous mutation frequency and emergence of ciprofloxacin resistance in Campylobacter jejuni and Campylobacter coli. J Antimicrob Chemother 60, 1251–1257.[CrossRef]
    [Google Scholar]
  10. Lin, J., Michel, L. O. & Zhang, Q. ( 2002; ). CmeABC functions as a multidrug efflux system in Campylobacter jejuni. Antimicrob Agents Chemother 46, 2124–2131.[CrossRef]
    [Google Scholar]
  11. Lin, J., Cagliero, C., Guo, B., Barton, Y. W., Maurel, M. C., Payot, S. & Zhang, Q. ( 2005; ). Bile salts modulate expression of the CmeABC multidrug efflux pump in Campylobacter jejuni. J Bacteriol 187, 7417–7424.[CrossRef]
    [Google Scholar]
  12. Lomovskaya, O., Warren, M. S., Lee, A., Galazzo, J., Fronko, R., Lee, M., Blais, J., Cho, D., Chamberland, S. & other authors ( 2001; ). Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother 45, 105–116.[CrossRef]
    [Google Scholar]
  13. Pannek, S., Higgins, P. G., Steinke, P., Jonas, D., Akova, M., Bohnert, J. A., Seifert, H. & Kern, W. V. ( 2006; ). Multidrug efflux inhibition in Acinetobacter baumannii: comparison between 1-(1-naphthylmethyl)-piperazine and phenyl-arginine-beta-naphthylamide. J Antimicrob Chemother 57, 970–974.[CrossRef]
    [Google Scholar]
  14. Payot, S., Avrain, L., Magras, C., Praud, K., Cloeckaert, A. & Chaslus-Dancla, E. ( 2004; ). Relative contribution of target gene mutation and efflux to fluoroquinolone and erythromycin resistance, in French poultry and pig isolates of Campylobacter coli. Int J Antimicrob Agents 23, 468–472.[CrossRef]
    [Google Scholar]
  15. Price, C. T., Lee, I. R. & Gustafson, J. E. ( 2000; ). The effects of salicylate on bacteria. Int J Biochem Cell Biol 32, 1029–1043.[CrossRef]
    [Google Scholar]
  16. Randall, L. P., Ridley, A. M., Cooles, S. W., Sharma, M., Sayers, A. R., Pumbwe, L., Newell, D. G., Piddock, L. J. & Woodward, M. J. ( 2003; ). Prevalence of multiple antibiotic resistance in 443 Campylobacter spp. isolated from humans and animals. J Antimicrob Chemother 52, 507–510.[CrossRef]
    [Google Scholar]
  17. Ruiz, J., Marco, F., Oliveira, I., Vila, J. & Gascon, J. ( 2007; ). Trends in antimicrobial resistance in Campylobacter spp. causing traveler's diarrhea. APMIS 115, 218–224.[CrossRef]
    [Google Scholar]
  18. Schumacher, A., Steinke, P., Bohnert, J. A., Akova, M., Jonas, D. & Kern, W. V. ( 2006; ). Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Enterobacteriaceae other than Escherichia coli. J Antimicrob Chemother 57, 344–348.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47823-0
Loading
/content/journal/jmm/10.1099/jmm.0.47823-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error